Rachel Glicksman

Jan 5, 2025 | redjournal.org | Rachel Glicksman

Clinical InvestigationArticles in PressOpen access 1Radiation Medicine Department, Princess Margaret Cancer Centre, University Health Network; Department of Radiation Oncology, University of Toronto 2Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network; Department of Medicine, University of Toronto 3Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network 4Departments of Surgery (Urology) and Surgical...

May 6, 2024 | redjournal.org | Rachel Glicksman

Get full text accessLog in, subscribe or purchase for full access. ReferencesGlicksman, RM ∙ Cheung, P ∙ Korol, R ... Stereotactic body radiotherapy for renal cell carcinoma: oncological and renal function outcomesClin Oncol (R Coll Radiol). 2023; 35:20-282. Siva, S ∙ Bressel, M ∙ Sidhom, M ... Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trialLancet Oncol. 2024; 25:308-3163.